September 19, 2008Journal of Hypertension
The metabolic syndrome in hypertension: European society of hypertension position statement
Why the study?
What is the recommended management for patients with metabolic syndrome and hypertension?
Population
Patients with metabolic syndrome and hypertension
Comparison
Lifestyle interventions and antihypertensive… vs Diuretics and classical beta-blockers
Design
Guideline
Authors
Discussion
Loading...
Member takes
Implication
Warrants routine metabolic syndrome screening in hypertension; reinforces integrated risk stratification in guidelines.
Structured PICO
What is the recommended management for patients with metabolic syndrome and hypertension?
P
Population
Patients with metabolic syndrome and hypertension
I
Intervention
Lifestyle interventions and antihypertensive therapy (ACE inhibitors, ARBs, or calcium channel blockers)
C
Comparator
Diuretics and classical beta-blockers
O
Outcome
Cardiovascular and renal events, and prevention of type 2 diabetes
This position statement outlines the pathogenesis and management of metabolic syndrome in hypertension, recommending ACEi/ARB/CCB over traditional beta-blockers and diuretics.
Cite This Study
Redón et al. (2008) conducted a review in Metabolic syndrome in hypertension. Lifestyle interventions and antihypertensive therapy was evaluated. Management of metabolic syndrome in hypertension should prioritize lifestyle interventions for weight reduction, with ACE inhibitors, ARBs, or CCBs preferred over diuretics and classical beta-blockers.